|
15 May 2019 |
Vertex and Kymera Therapeutics Establish Strategic Collaboration to Discover and Develop Targeted Protein Degradation Medicines for Serious Diseases
|
|
15 May 2019 |
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
|
|
14 May 2019 |
Zymeworks Enters its First ZymeLink™ Antibody-Drug Conjugate Platform Licensing Agreement with Iconic Therapeutics
|
|
12 May 2019 |
TriSalus Life Sciences’ Pressure-Enabled Drug Delivery (PEDD) Increases Penetration and Antitumor Activity of Anti-CEA CAR-T in Mouse Model of Liver Metastases
|
|
10 May 2019 |
Spectrum Announces Asset Purchase and License for a Novel Immuno-Oncology Platform including Two Early Stage Assets
|
|
10 May 2019 |
Takeda Simplifies Portfolio and Accelerates Deleveraging Through Two Divestitures
|
|
09 May 2019 |
Novartis to acquire Xiidra®, expanding front-of-eye portfolio and strengthening leadership in eye care
|
|
08 May 2019 |
Protagonist Therapeutics Expands PTG-200 Collaboration Agreement with Janssen to Include Second Generation Oral IL-23 Receptor Antagonists
|
|
08 May 2019 |
Curadev Announces Licensing Agreement With Takeda for Novel STING Agonist
|
|
08 May 2019 |
Gilead Sciences and Goldfinch Bio Announce Strategic Collaboration to Develop Novel Therapies for Kidney Disease
|
|
08 May 2019 |
BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio
|
|
08 May 2019 |
Pfizer Acquires Clinical-Stage Biotech Therachon
|
|
06 May 2019 |
Skyhawk Therapeutics Announces Agreement with Takeda to Develop Novel Small Molecule RNA Splicing Modifiers for Neurodegenerative Diseases
|
|
03 May 2019 |
Amgen And Syapse Enter Precision Medicine Collaboration In Oncology
|
|
02 May 2019 |
Transgene and AstraZeneca enter into a collaboration and exclusive license option agreement for innovative Invir.IOTM based armed oncolytic immunotherapies
|
|
01 May 2019 |
Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers
|
|
01 May 2019 |
AstraZeneca starts artificial intelligence collaboration to accelerate drug discovery
|
|
30 Apr 2019 |
Sandoz enters agreement for proposed trastuzumab biosimilar, currently in Phase III development, to treat selected HER2-positive cancer tumors
|
|
29 Apr 2019 |
Iktos Announces Research Collaboration with Janssen to Utilize Iktos’ Artificial Intelligence Technology to Increase Speed & Efficiency of Small Molecule Drug Discovery
|
|
29 Apr 2019 |
Calixar signs exclusive licensing agreement with Regeneron on undisclosed therapeutic target
|
|
25 Apr 2019 |
Daiichi Sankyo Selects Lead Candidate Built on Zymeworks’ Azymetric™ Bispecific Platform
|
|
25 Apr 2019 |
Salix Enters Into Exclusive License Agreement With Mitsubishi Tanabe Pharma To Develop And Commercialize Late Stage Investigational S1P Modulator For The Treatment Of Inflammatory Bowel Disease
|
|
24 Apr 2019 |
ADC Therapeutics and Adagene Announce License Agreement
|
|
23 Apr 2019 |
Lilly and Avidity Biosciences Announce Licensing and Research Collaboration
|
|
23 Apr 2019 |
Variant Pharmaceuticals Expands Development Focus Into $60+ Billion Anti-inflammatory Market with Worldwide License to Novel Inflammasome Inhibitor
|
